Table 1.
Class | Description | Probability of being Pathogenic | Clinical implication [16] | |
---|---|---|---|---|
According to IARC [9] | According to ACMG/AMP [19] | |||
1 | Benign (B)/ of no clinical significance | < 0.001 | < 0.001 |
Treat as if ‘no mutation detected’ for this disorder No Predictive testing of at risk relatives is suggested |
2 | Likely benign (LB)/ of little clinical significance | 0.001–0.049 | 0.001–0.099 | |
3 | Variant of unknown significance (VUS) | 0.050–0.949 | 0.100–0.899 |
Surveillance based on family history and patient-based risk factors Obtaining additional data in order to reclassify, if possible Research testing of family members can be recommended |
4 | Likely pathogenic (LP) | 0.950–0.999 | 0.900–0.999 |
Full high-risk surveillance Predictive testing of at-risk relatives is suggested |
5 | Pathogenic (P) | > 0.999 | > 0.999 |
In our study, we do not distinguish between pathogenic and likely pathogenic outcomes, but refer to them as P/LP